ICPME - PET Imaging and Beyond

2ND ANNUAL PERSPECTIVES IN BREAST CANCER CARE

Session 2: PET Imaging and Beyond
How is your imaging practice informing treatment and improving outcome for patients with breast cancer?

For more information, click on a lecture title below
The number of credit hours vary by lecture.

PET Imaging in Metastatic Breast Cancer Did you know that PET/CT is not the best test for loco-regional staging in early disease? Maxine S. Jochelson, MD, FSBI
Novel Strategies for Breast Cancer Assessment and Response Did you know that MRI is currently the best imaging study for evaluating response to neoadjuvant chemotherapy in locally advanced breast cancer? Bonnie N. Joe, MD, PhD
FES and FDG PET in ILC and IDC: Where Is the Clinical Impact? Are you using FES PET/CT for determining which patients will not respond to endocrine therapy? Gary A. Ulaner, MD, PhD, FACNM
Questions? For questions regarding this program, please contact ICPME: Email: information@icpmed.com PROVIDED BY